Search

Your search keyword '"Just, M"' showing total 1,920 results

Search Constraints

Start Over You searched for: Author "Just, M" Remove constraint Author: "Just, M"
1,920 results on '"Just, M"'

Search Results

3. Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

5. Empirical estimates of the mutation rate for an alphabaculovirus.

6. The role of citizen science in addressing grand challenges in food and agriculture research

8. Coevolution of hytrosaviruses and host immune responses

9. RNA interference-based antiviral immune response against the salivary gland hypertrophy virus in Glossina pallidipes

10. Enhancing vector refractoriness to trypanosome infection: achievements, challenges and perspectives

11. Hytrosavirus genetic diversity and eco-regional spread in Glossina species

12. Characterization and Tissue Tropism of Newly Identified Iflavirus and Negeviruses in Glossina morsitans morsitans Tsetse Flies

14. 109P Updated long-term overall survival of older adjuvant ibandronate-treated patients with intermediate- or high-risk early breast cancer compared with additional adjuvant capecitabine treatment: The ICE randomized clinical trial

15. Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial

22. Comparative Usutu and West Nile virus transmission potential by local Culex pipiens mosquitoes in north-western Europe

23. Expression Profile of Glossina pallidipes MicroRNAs During Symptomatic and Asymptomatic Infection With Glossina pallidipes Salivary Gland Hypertrophy Virus (Hytrosavirus)

24. Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)

29. 350MO Omission of chemotherapy and addition of the CDK4/6 inhibitor ribociclib in HER2-positive and hormone-receptor positive metastatic breast cancer – Second interim efficacy analysis of the randomized phase III DETECT V trial

31. LBA17 Survival outcome of neoadjuvant endocrine therapy + trastuzumab and pertuzumab (ET+T+P) vs. de-escalated chemotherapy (CT)+T+P in hormone receptor positive (HR+)/HER2+ early breast cancer (EBC): WSG-TP-II trial

32. Identification of Loci Associated with Enhanced Virulence in Spodoptera litura Nucleopolyhedrovirus Isolates Using Deep Sequencing

34. 94P Patient quality of life (QoL) from the GeparX trial on the addition of denosumab (Dmab) added to two different nab-paclitaxel (nP) regimens as neoadjuvant chemotherapy (NACT) in primary breast cancer (BC)

36. Patient quality of life (QoL) from the GeparX trial on the addition of denosumab (Dmab) added to two different nab-paclitaxel (nP) regimens as neoadjuvant chemotherapy (NACT) in primary breast cancer (BC)

37. White spot syndrome virus host range and impact on transmission

38. Updated list of QPS-recommended biological agents for safety risk assessments carried out by EFSA

39. Microbiological agents as notified to EFSA

40. Virology, Epidemiology and Pathology of Glossina Hytrosavirus, and Its Control Prospects in Laboratory Colonies of the Tsetse Fly, Glossina pallidipes (Diptera; Glossinidae)

43. Comparative analysis of salivary gland proteomes of two Glossina species with differential hytrosavirus pathologies

44. Functional Peroral Infectivity Complex of White Spot Syndrome Virus of Shrimp

45. Empirical estimates of the mutation rate for an alphabaculovirus

46. White spot syndrome virus host range and impact on transmission

47. Baculovirus DNA Replication

Catalog

Books, media, physical & digital resources